APA ציטוט

McCurdy, S., Keedy, K., Lawrence, L., Nenninger, A., Sheets, A., Quintas, M., & Cammarata, S. (2020). Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial. Antimicrob Agents Chemother.

Citação norma Chicago

McCurdy, Sandra, Kara Keedy, Laura Lawrence, Ashley Nenninger, Amanda Sheets, Megan Quintas, and Sue Cammarata. "Efficacy of Delafloxacin Versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial." Antimicrob Agents Chemother 2020.

ציטוט MLA

McCurdy, Sandra, et al. "Efficacy of Delafloxacin Versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial." Antimicrob Agents Chemother 2020.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.